Intellipharmaceutics International Inc. (Nasdaq: IPCI) updates on its generic drug commercialization activities.

From the release: "AstraZeneca Pharmaceuticals LP (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE